Statistics at FDA: Reflections on the Past Six Years-Reference-Cited by-同舟云学术

Statistics at FDA: Reflections on the Past Six Years

Published:2019-01-02 Issue:1 Volume:11 Page:1-12
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

LaVange Lisa M.¹

Affiliation:

1. Department of Biostatistics, University of North Carolina at Chapel Hill, NC

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2019.1571322

Reference72 articles.

1. Estimands and Their Role in Clinical Trials

2. Estimands in clinical trials - broadening the perspective

3. Statistical Considerations on Subgroup Analysis in Clinical Trials

4. American Statistical Association (2016), “Statistics Degrees Continue Strong Growth,” Amstat News, Oct. 2016, available at http://magazine.amstat.org/blog/2015/10/01/statistics-degrees-continue-strong-growth/.

5. I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes” by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, and Michael Rosenblum;Biometrics;2021-06-09

2. A BAYESIAN ADAPTIVE TWO-STAGE DESIGN FOR PEDIATRIC CLINICAL TRIALS;Journal of Biopharmaceutical Statistics;2020-10-05

3. Biostatistics in Clinical Trials;Quantitative Methods in Pharmaceutical Research and Development;2020

4. Beyond Randomized Clinical Trials: Use of External Controls;Clinical Pharmacology & Therapeutics;2019-12-17

5. Equivalence of regression curves sharing common parameters;Biometrics;2019-11